Is a 1:1 Environment Good Enough? by Bryan Artman, Philip Lai, Rachel Kathman, Rebecca M Nelson

Get full text

Adaptation of a human gut epithelial model in relation to the assessment of clinical pharmacokinetic parameters for selected tyrosine kinase inhibitors by Richard Honeywell, Christien Fatmawati, Marita Buddha, Sarina Hitzerd, Ietje Kathman, Godefridus Peters

Get full text

Population pharmacokinetic–pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers by Steven J. Kathman, Jeffery J. Wheeler, Deepak L. Bhatt, Susan E. Arnold, John S. Lee

Get full text

GFR Estimation After Cystatin C Reference Material Change by Stefanie W. Benoit, Thelma Kathman, Jay Patel, Melinda Stegman, Cristina Cobb, Jonathan Hoehn, Prasad Devarajan, Edward J. Nehus

Get full text

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours. by Blagden, S, Molife, L, Seebaran, A, Payne, M, Reid, A, Protheroe, A, Vasist, L, Williams, D, Bowen, C, Kathman, S, Hodge, J, Dar, M, de Bono, J, Middleton, MR

Deciding Which Way to Go: How Do Insects alter Movements to Negotiate Barriers? by Roy E. Ritzmann, Cynthia M. Harley, Kathryn A. Daltorio, Brian R. Tietz, Alan J. Pollack, John A. Bender, Peiyuan eGuo, Audra L. Horomanski, Nicholas D. Kathman, Claudia eNieuwoudt, Amy E. Brown, Roger D. Quinn

Get full text